Compare Quest Diagnostics Inc (DGX) vs iShares MSCI South Africa ETF (EZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs iShares MSCI South Africa ETF — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.95B), while iShares MSCI South Africa ETF trades at $63.48. The key difference: Quest Diagnostics Inc pays a 1.66% dividend while iShares MSCI South Africa ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares MSCI South Africa ETF nearer its low. Which is the better fit depends on your goals.
| DGX | EZA | |
|---|---|---|
Market Cap | $22.95B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $216.02 | $81.60 |
52-Week Low | $166.42 | $52.86 |
Enterprise Value | $28.97B | — |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →
